Companies collaborate at Danaher Life Sciences Biologics Day to present the latest technological developments for biopharmaceutical analysis

SCIEX features its ground-breaking biologics solutions including the X500B QTOF System and the Fast Glycan Labeling and Analysis Kit April 11, 2017 Framingham, MA — SCIEX, a Danaher company and global leader in life science analytical technologies, today announced that it presented the company’s latest ground-breaking biologics solutions at the Danaher Life Sciences Biologics Day.... Read more

Danaher Announces Appointment of Raymond C. Stevens, Ph.D. to Danaher Board

Danaher Announces Appointment of Raymond C. Stevens, Ph.D. to Danaher Board WASHINGTON, Feb. 21, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it has appointed Raymond C. Stevens, Ph.D. to its Board of Directors. Professor Stevens is currently Provost Professor of Biological Sciences and Chemistry, and Director of The Bridge Institute, at the... Read more

Danaher To Present At Barclays Industrial Select Conference

WASHINGTON, Feb. 16, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Barclays Industrial Select Conference in Miami, Florida on Thursday, February 23, 2017 at 9:10 a.m. ET. The audio will be simultaneously webcast on www.danaher.com.  About Danaher Danaher is a... Read more

Danaher To Present At J.P. Morgan Healthcare Conference

Danaher To Present At J.P. Morgan Healthcare Conference WASHINGTON, Jan. 4, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 10, 2017 at 11:30 a.m. PT. The audio will be simultaneously... Read more

Danaher announces leadership appointment

WASHINGTON, Dec. 1, 2016 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that effective January 1, 2017, Rainer Blair has been promoted to Executive Vice President of Danaher Corporation, with responsibility for the Company’s $5 billion Life Sciences platform. Mr. Blair, 52 years old, has served in a series of progressively more responsible general management... Read more

Danaher To Webcast Investor And Analyst Meeting

WASHINGTON, Nov. 14, 2016 /PRNewswire/ — Danaher Corporation (NYSE:DHR) will host a live video webcast of its Investor and Analyst Meeting on December 15, 2016 beginning at 9:30 a.m. ET and concluding at approximately 1:00 p.m. The link to the webcast will be available on the “Investors” section of Danaher’s website, www.danaher.com, under the subheading “Events... Read more

Danaher Completes Acquisition Of Cepheid

WASHINGTON, Nov. 4, 2016 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) announced that today it completed its acquisition of Cepheid (NASDAQ: CPHD). Copper Merger Sub, Inc. (“Copper”), a California corporation and an indirect wholly owned subsidiary of Danaher, has merged into Cepheid and, as a result, Cepheid has become an indirect wholly owned subsidiary of Danaher.... Read more

Danaher to Present at Baird Industrial Conference

WASHINGTON, Oct. 31, 2016 /PRNewswire/ — Danaher Corporation (NYSE:DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Baird 2016 Global Industrial Conference in Chicago, Illinois on Wednesday, November 9, 2016 at 8:00 a.m. CT. The audio will be simultaneously webcast and the presentation will be archived on... Read more

Danaher To Present At Morgan Stanley Laguna Conference

WASHINGTON, Sept. 8, 2016 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will be presenting at the Morgan Stanley Laguna Conference in Dana Point, California on Thursday, September 15, 2016 at 9:20 a.m. PT. The audio will be simultaneously webcast and the presentation will be archived... Read more

Danaher To Acquire Cepheid For $53.00 Per Share, Or Approximately $4 Billion

WASHINGTON, Sept. 6, 2016 /PRNewswire/ — Danaher Corporation (NYSE:DHR) (“Danaher” or the “Company”) announced today that it has entered into a definitive merger agreement with Cepheid (NASDAQ:CPHD) pursuant to which Danaher will acquire all of the outstanding shares of Cepheid for $53.00 per share in cash, or a total enterprise value of approximately $4 billion... Read more